ロード中...
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
BACKGROUND: The mechanism of action of oral cladribine, recently licensed for relapsing multiple sclerosis, is unknown. OBJECTIVE: To determine whether cladribine depletes memory B cells consistent with our recent hypothesis that effective, disease-modifying treatments act by physical/functional dep...
保存先:
| 出版年: | J Neurol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5937883/ https://ncbi.nlm.nih.gov/pubmed/29550884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-018-8830-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|